3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
March 24, 2009 - Abbott said today it initiated the next phase of the ABSORB clinical trial to evaluate the safety and ...
March 24, 2009
March 13, 2009 - A comprehensive analysis published this week in The Lancet from the ABSORB clinical trial demonstrated ...
March 13, 2009
March 10, 2009 - Abbott today launched the VOYAGER NC Coronary Dilatation Catheter, a next-generation balloon dilatation ...
March 10, 2009
Abbott's StarClose SE Vascular Closure System, a next-generation vessel closure device, is engineered to enable fast and ...
February 24, 2009
VOYAGER NC is Abbott's next-generation balloon dilatation catheter for the treatment of coronary artery disease ...
February 24, 2009
Abbott Vascular's XIENCE V Everolimus-Eluting Coronary is indicated for improving coronary luminal diameter in patients ...
February 10, 2009January 28, 2009 - Data published this week in the online journal Circulation from the SPIRIT III U.S. pivotal trial ...
January 27, 2009December 18, 2008 - Abbott this week said it started the SPIRIT Small Vessel, a clinical trial evaluating a 2.25mm size ...
December 17, 2008December 15, 2008 - The FDA has approved Abbott's TRILIPIX (fenofibric acid) delayed-release capsules, the first and ...
December 15, 2008October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting ...
October 29, 2008